{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:15:30Z","timestamp":1790511330392,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.neurobiolaging.2021.08.002","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T09:25:33Z","timestamp":1628414733000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-4243","authenticated-orcid":false,"given":"Eline A.J.","family":"Willemse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1278-6605","authenticated-orcid":false,"given":"Anne","family":"Sieben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charisse","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Vermeiren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"De Roeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Van Broeckhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1924-2029","authenticated-orcid":false,"given":"Bart","family":"De Vil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Cras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-2964","authenticated-orcid":false,"given":"Peter P.","family":"De Deyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-9785","authenticated-orcid":false,"given":"Sebastiaan","family":"Engelborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bjerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0001","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-018-0279-z","article-title":"Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase","volume":"13","author":"Becker","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0003","article-title":"CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD","author":"Blennow","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry jnnp-2018-320155"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2021.08.002_bib0004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jnc.13600","article-title":"Tau physiology and pathomechanisms in frontotemporal lobar degeneration","volume":"138","author":"Bodea","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0005","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1212\/WNL.54.5.1095","article-title":"Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates","volume":"54","author":"Brandel","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004569","article-title":"Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers","author":"Casaletto","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0008","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012145","article-title":"Tripartite relationship among synaptic, amyloid, and tau proteins: an In Vivo and Postmortem Study","author":"Casaletto","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0009","volume":"135","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S1041610298005110","article-title":"Neurochemical dissection of synaptic pathology in Alzheimer's disease","volume":"10","author":"Davidsson","year":"1998","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0011","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jalz.2015.05.012","article-title":"C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease","volume":"11","author":"De Vos","year":"2015","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0012","doi-asserted-by":"crossref","unstructured":"De Vos, A., Jacobs, D., Struyfs, H., Pareyn, I., Vanhoorelbeke, K., Maes, W., Blennow, K., Zetterberg, H., Engelborghs, S., Vanmechelen, E., 2015b. A Monoclonal Antibody based ELISA for Neurogranin, in: Alzheimer's Association International Conference. p. 10980.","DOI":"10.1016\/j.jalz.2015.08.061"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0013","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0014","first-page":"264","article-title":"Vascular dementia Cognitive, functional and behavioral assessment Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part II. Dement","volume":"5","author":"Engelhardt","year":"2011","journal-title":"Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0015","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jalz.2014.12.006","article-title":"CSF biomarkers for the differential diagnosis of Alzheimer's disease. A large-scale international multicenter study","volume":"11","author":"Ewers","year":"2015","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0016","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02740632","article-title":"RC3\/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes","volume":"15","author":"Gerendasy","year":"1997","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0017","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3233\/JAD-151111","article-title":"Differential diagnosis of dementia with high levels of cerebrospinal fluid tau protein","volume":"51","author":"Grangeon","year":"2016","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0018","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005057","article-title":"Neurogranin as a predictor of memory and executive function decline in MCI patients","author":"Headley","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-015-0161-y","article-title":"Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease","volume":"7","author":"Hellwig","year":"2015","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104645","article-title":"Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration","volume":"134","author":"H\u00f6glund","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0022","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0023","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/acn3.266","article-title":"Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease","volume":"3","author":"Janelidze","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2015.12.013","article-title":"Neurogranin restores amyloid \u03b2-mediated synaptic transmission and long-term potentiation deficits","volume":"277","author":"Kaleka","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0025","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","article-title":"Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease","volume":"72","author":"Kester","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0026","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease","volume":"11","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0027","article-title":"The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease","author":"Kvartsberg","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0028","first-page":"11","article-title":"Molecular biomarkers of Alzheimer's disease: progress and prospects","author":"Lashley","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0029","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-140771","article-title":"Amyloid-\u03b2 42\/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays","volume":"43","author":"Lewczuk","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41398-020-0801-2","article-title":"Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment","volume":"10","author":"Liu","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0031","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jalz.2015.10.009","article-title":"Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia","volume":"12","author":"Llorens","year":"2016","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0032","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"A harmonized classification system for FTLD-TDP pathology","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0034","series-title":"Neuropathology of dementing disorders","author":"Markesbery","year":"1998"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0035","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/emmm.201606540","article-title":"Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease","volume":"8","author":"Mattsson","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0036","first-page":"1","article-title":"A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer's disease and mild cognitive impairment","author":"Mavroudis","year":"2019","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0037","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0038","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/alz.12239","article-title":"Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers","volume":"17","author":"Mielke","year":"2021","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0039","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jalz.2019.07.009","article-title":"Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin","volume":"15","author":"Mielke","year":"2019","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0040","doi-asserted-by":"crossref","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","article-title":"Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation","volume":"287","author":"Mondrag\u00f3n-Rodr\u00edguez","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0042","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0043","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-170927","article-title":"Added diagnostic value of cerebrospinal fluid biomarkers for differential dementia diagnosis in an autopsy-confirmed cohort","volume":"63","author":"Niemantsverdriet","year":"2018","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0044","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-170327","article-title":"The cerebrospinal fluid A\u03b21-42\/A\u03b21-40 ratio improves concordance with amyloid-PET for diagnosing alzheimer's disease in a clinical setting","volume":"60","author":"Niemantsverdriet","year":"2017","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1099-1166(199804)13:4<203::AID-GPS734>3.0.CO;2-B","article-title":"Alcohol related dementia: proposed clinical criteria","volume":"13","author":"Oslin","year":"1998","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0046","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-018-1851-x","article-title":"Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology","volume":"136","author":"Portelius","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0047","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0048","unstructured":"R Core Team, 2020. R: A language and environment for statistical computing."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0049","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0050","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00702-016-1597-3","article-title":"Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD","volume":"123","author":"Sanfilippo","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.12.019","article-title":"Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease","author":"Schindler","year":"2019","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0052","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000489847","article-title":"Neurogranin and BACE1 in CSF as potential biomarkers differentiating depression with cognitive deficits from early Alzheimer's disease: a pilot study","volume":"8","author":"Schipke","year":"2018","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0053","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3233\/JAD-151097","article-title":"A decade of cerebrospinal fluid biomarkers for Alzheimer's Disease in Belgium","volume":"54","author":"Somers","year":"2016","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2016.05.003","article-title":"APOE \u03b54 carriers may undergo synaptic damage conferring risk of Alzheimer's disease","author":"Sun","year":"2016","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.01.012","article-title":"Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease","author":"Sutphen","year":"2018","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0056","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease","volume":"73","author":"Tarawneh","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0057","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2010.09.073","article-title":"Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease","volume":"1362","author":"Thorsell","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0058","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-014-0090-1","article-title":"The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease","volume":"7","author":"Vermeiren","year":"2015","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0059","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4103\/1673-5374.268901","article-title":"Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis","volume":"15","author":"Villar-Pique","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40520-018-0948-3","article-title":"Association of cerebrospinal fluid Neurogranin with Alzheimer's disease","volume":"31","author":"Wang","year":"2019","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0061","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to Alzheimer disease","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0062","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/acn3.518","article-title":"CSF neurogranin or tau distinguish typical and atypical Alzheimer disease","volume":"5","author":"Wellington","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0063","article-title":"Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study","volume":"2017","author":"Willemse","year":"2018","journal-title":"Clin. Chem. clinchem."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0064","first-page":"12","article-title":"Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer's disease","author":"Xue","year":"2020","journal-title":"Aging (Albany. NY)."},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0065","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.08.002_bib0066","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021002542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021002542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:39:41Z","timestamp":1759318781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021002542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":66,"alternative-id":["S0197458021002542"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.08.002","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}